Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 3 , Pages 199-206 , May 2009

The pattern of cognitive symptoms predicts time to dementia onset

  • Simona Sacuiu

      Affiliations

    • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-31-343-86-76; Fax: +46-31-776-04-03.
    • ,
  • Deborah Gustafson

      Affiliations

    • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden
    • Medical College of Wisconsin, Milwaukee, WI, USA
    • ,
  • Boo Johansson

      Affiliations

    • Institute of Psychology, University of Gothenburg, Gothenburg, Sweden
    • ,
  • Valgeir Thorvaldsson

      Affiliations

    • Institute of Psychology, University of Gothenburg, Gothenburg, Sweden
    • ,
  • Stig Berg

      Affiliations

    • Institute of Gerontology, School of Health Sciences, Jönköping University, Jönköping, Sweden
    • ,
  • Magnus Sjögren

      Affiliations

    • Neurotec Huddinge, Karolinska Institute, Stockholm, Sweden
    • ,
  • Xinxin Guo

      Affiliations

    • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden
    • ,
  • Svante Östling

      Affiliations

    • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden
    • ,
  • Ingmar Skoog

      Affiliations

    • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden

References 

  1. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000;57:808–813
  2. La Rue A, Jarvik LF. Cognitive function and prediction of dementia in old age. Int J Aging Hum Dev. 1987;25:79–89
  3. Persson G, Skoog I. Subclinical dementia: relevance of cognitive symptoms and signs. J Geriatr Psychiatry Neurol. 1992;5:172–178
  4. Tierney MC, Yao C, Kiss A, McDowell I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology. 2005;64:1853–1859
  5. Backman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain. 2001;124:96–102
  6. Fabrigoule C, Rouch I, Taberly A, Letenneur L, Commenges D, Mazaux JM, et al. Cognitive process in preclinical phase of dementia. Brain. 1998;121(Pt 1):135–141
  7. Nielsen H, Lolk A, Andersen K, Andersen J, Kragh-Sorensen P. Characteristics of elderly who develop Alzheimer's disease during the next two years-a neuropsychological study using CAMCOG: the Odense Study. Int J Geriatr Psychiatry. 1999;14:957–963
  8. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol. 2000;57:839–844
  9. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–1992
  10. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308
  11. Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol. 2001;58:411–416
  12. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry. 2006;63:916–924
  13. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198–205
  14. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology. 2006;67:2176–2185
  15. Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology. 2007;68:1909–1916
  16. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68:288–291
  17. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–1599
  18. Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green RC, Hayden K, et al. Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology. 2006;67:229–234
  19. Sacuiu S, Sjogren M, Johansson B, Gustafson D, Skoog I. Prodromal cognitive signs of dementia in 85-year-olds using four sources of information. Neurology. 2005;65:1894–1900
  20. Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC, et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology. 2004;63:2341–2347
  21. Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain. 2005;128:1093–1101
  22. Berg L, McKeel DW, Miller JP, Storandt M, Rubin EH, Morris JC, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998;55:326–335
  23. Hansen LA, DeTeresa R, Davies P, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology. 1988;38:48–54
  24. MRC-CFAS. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales: Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS). Lancet. 2001;357:169–175
  25. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813–817
  26. Persson G. Prevalence of mental disorders in a 70-year-old urban population. Acta Psychiatr Scand. 1980;62:119–139
  27. Aevarsson O, Skoog I. Dementia disorders in a birth cohort followed from age 85 to 88: the influence of mortality, refusal rate, and diagnostic change on prevalence. Int Psychogeriatr. 1997;9:11–23
  28. Nilsson LV. Incidence of severe dementia in an urban sample followed from 70 to 79 years of age. Acta Psychiatr Scand. 1984;70:478–486
  29. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141–1145
  30. Rinder L, Roupe S, Steen B, Svanborg A. Seventy-year-old people in Gothenburg: a population study in an industrialized Swedish city. Acta Med Scand. 1975;198:397–407
  31. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993;328:153–158
  32. Nilsson LV, Persson G. Prevalence of mental disorders in an urban sample examined at 70, 75 and 79 years of age. Acta Psychiatr Scand. 1984;69:519–527
  33. Nilsson L. Prevalence of mental disorders in a 70-year-old urban sample: a cohort comparison. J Clinical Experimental Gerontology. 1983;5:101–120
  34. Skoog I. Mental disorders in the elderly: a population study in 85-year-olds (PhD thesis). Göteborg: University of Göteborg; 1993;
  35. Andersson E, Berg S, Lawenius M, Svanborg A. Intellectual functioning in a 70-year-old urban population. Acta Psychiatr Scand. 1978;57:59–66
  36. Berg S. Psychological functioning in 70- and 75-year-old people: a study in an industrialized city. Acta Psychiatr Scand Suppl. 1980;288:1–47
  37. Skoog I, Berg S, Johansson B, Palmertz B, Andreasson LA. The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds. Acta Neurol Scand. 1996;93:142–148
  38. Wechsler D. The measurement and appraisal of adult intelligence. 4th ed.. Baltimore: Williams & Wilkins; 1958;
  39. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment: beyond controversies, towards a consensus—report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–246
  40. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163:1524–1528
  41. APA . Diagnostic and statistical manual of mental disorders. rev 3rd ed.. Washington: American Psychiatric Association; 1987;
  42. Mielke MM, Zandi PP, Sjogren M, Gustafson D, Ostling S, Steen B, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689–1695
  43. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005;76:1479–1484
  44. Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, et al. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease: a study of a community-based population. Arch Neurol. 1996;53:1056–1061
  45. Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB. Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol A Biol Sci Med Sci. 1995;50A:M49–M55
  46. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128:2034–2041
  47. Jellinger KA, Mitter-Ferstl E. The impact of cerebrovascular lesions in Alzheimer disease: a comparative autopsy study. J Neurol. 2003;250:1050–1055
  48. Borjesson-Hanson A, Gustafson D, Skoog I. Five-year mortality in relation to dementia and cognitive function in 95-year-olds. Neurology. 2007;69:2069–2075
  49. Johansson B, Zarit SH. Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Geriatr Psychiatry. 1997;12:53–59
  50. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology. 2003;61:1179–1184

PII: S1552-5260(08)02893-8

doi: 10.1016/j.jalz.2008.10.007

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 3 , Pages 199-206 , May 2009

Article Tools

* Image Usage & Resolution